{"id":50782,"date":"2022-11-11T23:02:41","date_gmt":"2022-11-11T22:02:41","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\/"},"modified":"2022-11-11T23:02:41","modified_gmt":"2022-11-11T22:02:41","slug":"ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\/","title":{"rendered":"Ventas to Participate in Investor Meetings at Nareit\u2019s REITworld 2022 Annual Conference"},"content":{"rendered":"<div>\n<p>CHICAGO&#8211;(BUSINESS WIRE)&#8211;Ventas, Inc. (NYSE: VTR) (\u201cVentas\u201d or the \u201cCompany\u201d) announced today that management will participate in investor meetings at Nareit\u2019s REITworld 2022 Annual Conference (the \u201cNareit Conference\u201d) on November 15-16, 2022.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221111005540\/en\/282462\/5\/Ventas_logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221111005540\/en\/282462\/21\/Ventas_logo.jpg\"><\/a><\/p>\n<p>\nAny Company written materials accompanying the participation at the Nareit Conference will be available on the Company\u2019s website on or about November 14, 2022. These materials will be archived at ir.ventasreit.com\/events-and-presentations for a limited period following the event.\n<\/p>\n<p>\n<b><span class=\"bwuline\">About Ventas<\/span><\/b>\n<\/p>\n<p>\nVentas Inc., an S&amp;P 500 company, operates at the intersection of two large and dynamic industries \u2013 healthcare and real estate. Fueled by powerful demographic demand from growth in the aging population, Ventas owns a diversified portfolio of over 1,200 properties in the United States, Canada and the United Kingdom. Ventas uses the power of its capital to unlock the value of senior living communities; life science, research &amp; innovation properties; medical office &amp; outpatient facilities, hospitals and other healthcare real estate. A globally-recognized real estate investment trust, Ventas follows a successful long-term strategy, proven over more than 20 years, built on diversification of property types, capital sources and industry leading partners, financial strength and flexibility, consistent and reliable growth and industry leading ESG achievements, managed by a collaborative and experienced team dedicated to its stakeholders.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nBJ Grant<br \/>\n<br \/>(877) 4-VENTAS\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>CHICAGO&#8211;(BUSINESS WIRE)&#8211;Ventas, Inc. (NYSE: VTR) (\u201cVentas\u201d or the \u201cCompany\u201d) announced today that management will participate in investor meetings at Nareit\u2019s REITworld 2022 Annual Conference (the \u201cNareit Conference\u201d) on November 15-16, 2022. Any Company written materials accompanying the participation at the Nareit Conference will be available on the Company\u2019s website on or about November 14, 2022. &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50782","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ventas to Participate in Investor Meetings at Nareit\u2019s REITworld 2022 Annual Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ventas to Participate in Investor Meetings at Nareit\u2019s REITworld 2022 Annual Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CHICAGO&#8211;(BUSINESS WIRE)&#8211;Ventas, Inc. (NYSE: VTR) (\u201cVentas\u201d or the \u201cCompany\u201d) announced today that management will participate in investor meetings at Nareit\u2019s REITworld 2022 Annual Conference (the \u201cNareit Conference\u201d) on November 15-16, 2022. Any Company written materials accompanying the participation at the Nareit Conference will be available on the Company\u2019s website on or about November 14, 2022. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-11T22:02:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221111005540\/en\/282462\/21\/Ventas_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Ventas to Participate in Investor Meetings at Nareit\u2019s REITworld 2022 Annual Conference\",\"datePublished\":\"2022-11-11T22:02:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\\\/\"},\"wordCount\":224,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221111005540\\\/en\\\/282462\\\/21\\\/Ventas_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\\\/\",\"name\":\"Ventas to Participate in Investor Meetings at Nareit\u2019s REITworld 2022 Annual Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221111005540\\\/en\\\/282462\\\/21\\\/Ventas_logo.jpg\",\"datePublished\":\"2022-11-11T22:02:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221111005540\\\/en\\\/282462\\\/21\\\/Ventas_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221111005540\\\/en\\\/282462\\\/21\\\/Ventas_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ventas to Participate in Investor Meetings at Nareit\u2019s REITworld 2022 Annual Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ventas to Participate in Investor Meetings at Nareit\u2019s REITworld 2022 Annual Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\/","og_locale":"en_US","og_type":"article","og_title":"Ventas to Participate in Investor Meetings at Nareit\u2019s REITworld 2022 Annual Conference - Pharma Trend","og_description":"CHICAGO&#8211;(BUSINESS WIRE)&#8211;Ventas, Inc. (NYSE: VTR) (\u201cVentas\u201d or the \u201cCompany\u201d) announced today that management will participate in investor meetings at Nareit\u2019s REITworld 2022 Annual Conference (the \u201cNareit Conference\u201d) on November 15-16, 2022. Any Company written materials accompanying the participation at the Nareit Conference will be available on the Company\u2019s website on or about November 14, 2022. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-11T22:02:41+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221111005540\/en\/282462\/21\/Ventas_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Ventas to Participate in Investor Meetings at Nareit\u2019s REITworld 2022 Annual Conference","datePublished":"2022-11-11T22:02:41+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\/"},"wordCount":224,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221111005540\/en\/282462\/21\/Ventas_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\/","url":"https:\/\/pharma-trend.com\/en\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\/","name":"Ventas to Participate in Investor Meetings at Nareit\u2019s REITworld 2022 Annual Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221111005540\/en\/282462\/21\/Ventas_logo.jpg","datePublished":"2022-11-11T22:02:41+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221111005540\/en\/282462\/21\/Ventas_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221111005540\/en\/282462\/21\/Ventas_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ventas-to-participate-in-investor-meetings-at-nareits-reitworld-2022-annual-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Ventas to Participate in Investor Meetings at Nareit\u2019s REITworld 2022 Annual Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50782","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50782"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50782\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50782"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50782"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50782"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}